Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565). | J Pain Res;13: 3059-3069, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565).

Nalamachu, Srinivas; Pergolizzi, Joseph; Kaye, Randall.

Affiliation

Nalamachu S; Mid America PolyClinic, Overland Park, KS, USA.
Pergolizzi J; NEMA Research, Naples, FL, USA.
Kaye R; Neurana Pharmaceuticals, Inc., San Diego, CA, USA.

J Pain Res ; 13: 3059-3069, 2020.

Article in En | MEDLINE | ID: mdl-33262641

Key words

acute muscle spasm; skeletal muscle relaxant; somnolence; tolperisone

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Pain Res Year: 2020 Document type: Article Affiliation country: United States Country of publication: New Zealand

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Pain Res Year: 2020 Document type: Article Affiliation country: United States Country of publication: New Zealand